These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25001509)

  • 1. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
    Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
    Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients.
    Wang M; Zhu X; Sha Z; Li N; Li D; Chen L
    Br J Cancer; 2015 Mar; 112(5):874-82. PubMed ID: 25668010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
    Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
    Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
    Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
    Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
    Zhao B; Han H; Chen J; Zhang Z; Li S; Fang F; Zheng Q; Ma Y; Zhang J; Wu N; Yang Y
    Cancer Lett; 2014 Jan; 342(1):43-51. PubMed ID: 23981581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.
    Shan N; Shen L; Wang J; He D; Duan C
    Biochem Biophys Res Commun; 2015 Jan; 456(1):385-91. PubMed ID: 25475731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
    Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
    Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
    Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
    Zhang B; Liu T; Wu T; Wang Z; Rao Z; Gao J
    Int J Biol Macromol; 2015 Mar; 74():111-8. PubMed ID: 25498886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
    Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
    Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
    Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
    Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
    Huang J; Sun C; Wang S; He Q; Li D
    Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
    Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
    Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of CLDN1 and insulin-like growth factor 2 are associated with poor prognosis in stage N2 non-small cell lung cancer.
    Zhang ZF; Pei BX; Wang AL; Zhang LM; Sun BS; Jiang RC; Wang CL
    Chin Med J (Engl); 2013; 126(19):3668-74. PubMed ID: 24112161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
    Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
    Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.